180 Life Sciences Corp (ATNF)

FINANCE: CORPORATE FINANCE
SIC: PHARMACEUTICAL PREPARATIONS

830 MENLO AVENUE, SUITE 100 MENLO PARK, CA 94025

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world's biggest drivers of disease - inflammation. The Company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company's primary platform is a novel program to treat fibrosis using anti-TNF, with its lead program in phase 2b/3 clinical trials.

Data as of 2021-06-19 12:34:51 -0400
Market Cap185.189 Million Shares Outstanding18.032 Million Avg 30-day Volume371.614 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low13.05 / 1.9 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ATNF instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 22 22 0.0% 8 (0.47%) 13 (0.75%) -38.46%
13F shares: 1.619 Million 4.312 Million -62.46% 696.921 Thousand 2.495 Million -72.06%
% Ownership 8.977 17.6705 -49.2% 3.8649 10.2235 -62.2%
New Positions: 14 20 -30.0% 6 12 -50.0%
Increased Positions 2 1 100.0% 2 1 100.0%
Closed Positions 14 4 250.0% 11 1 1000.0%
Reduced Positions 4
Total Calls 1.382 Million 215.3 Thousand
Total Puts 173.112 Thousand 30.4 Thousand
PUT/CALL Ratio 0.13 0.14
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ATNF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATNF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STEINMAN LAWRENCE

  • Director
592,358 2021-04-07 2

FELDMANN MARC

  • Director
2,617,758 2021-04-07 2

ROTHBARD JONATHAN B. CHIEF SCIENTIFIC OFFICER

  • Officer
560,449 2021-04-07 2

MCGOVERN JR. DONALD A.

  • Director
2,503 2021-03-04 3

GOLD LAWRENCE MARSHALL

  • Director
2,101 2021-03-04 3

WOODY JAMES N. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,425,252 2021-02-26 3

PAMIR OZAN INTERIM CFO

  • Officer
252,608 2021-02-26 2

KRAUSS MARLENE

KBL IV SPONSOR LLC

  • 10% Owner
2,353,569 2020-12-14 1

BARKER RICHARD W

  • Director
0 2020-12-03 2

SHENDELMAN SHOSHANA

  • Director
0 2020-11-06 1

OXFORD ASSET MANAGEMENT LLP

  • 10% Owner
132,285 2019-10-09 0

MIZUHO SECURITIES USA LLC

  • 10% Owner
964,000 2019-08-12 0

WEISS ASSET MANAGEMENT LP

WEISS ANDREW M

WAM GP LLC

  • 10% Owner
757,860 2019-06-05 0

POLAR ASSET MANAGEMENT PARTNERS INC.

  • 10% Owner
0 2019-03-06 0

HORNIG GEORGE R

  • Director
0 2017-06-01 0

NEFF P SHERRILL

  • Director
0 2017-06-01 0

KRAUSS MARLENE CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
2,875,000 2017-06-01 0

WILLIAMSON JOSEPH CHIEF OPERATING OFFICER

  • Officer
  • Director
0 2017-06-01 0

SHERMAN ANDREW

  • Director
0 2017-06-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
180 LIFE SCIENCES CORP ATNF 2021-06-23 19:15:03 UTC -57.9656 58.0456 500000
180 LIFE SCIENCES CORP ATNF 2021-06-23 18:45:02 UTC -57.9656 58.0456 500000
180 LIFE SCIENCES CORP ATNF 2021-06-23 18:15:03 UTC -57.9656 58.0456 500000
180 LIFE SCIENCES CORP ATNF 2021-06-23 17:45:02 UTC -57.9656 58.0456 500000
180 LIFE SCIENCES CORP ATNF 2021-06-23 17:15:03 UTC -57.9656 58.0456 500000
180 LIFE SCIENCES CORP ATNF 2021-06-23 16:45:03 UTC -58.0189 58.0989 500000
180 LIFE SCIENCES CORP ATNF 2021-06-23 16:15:03 UTC -58.0189 58.0989 500000
180 LIFE SCIENCES CORP ATNF 2021-06-23 15:45:03 UTC -58.0189 58.0989 400000
180 LIFE SCIENCES CORP ATNF 2021-06-23 15:15:03 UTC -58.0189 58.0989 400000
180 LIFE SCIENCES CORP ATNF 2021-06-23 14:45:03 UTC -58.1774 58.2574 400000
180 LIFE SCIENCES CORP ATNF 2021-06-23 14:15:02 UTC -58.1774 58.2574 300000
180 LIFE SCIENCES CORP ATNF 2021-06-23 13:45:03 UTC -58.1774 58.2574 300000
180 LIFE SCIENCES CORP ATNF 2021-06-23 13:15:03 UTC -58.1774 58.2574 300000
180 LIFE SCIENCES CORP ATNF 2021-06-23 12:45:03 UTC -58.1774 58.2574 300000
180 LIFE SCIENCES CORP ATNF 2021-06-22 22:15:03 UTC -58.1774 58.2574 550000
180 LIFE SCIENCES CORP ATNF 2021-06-22 21:45:03 UTC -58.1774 58.2574 550000
180 LIFE SCIENCES CORP ATNF 2021-06-22 21:15:02 UTC -58.1774 58.2574 550000
180 LIFE SCIENCES CORP ATNF 2021-06-22 20:45:03 UTC -58.1774 58.2574 550000
180 LIFE SCIENCES CORP ATNF 2021-06-22 20:15:04 UTC -58.1774 58.2574 550000
180 LIFE SCIENCES CORP ATNF 2021-06-22 19:45:03 UTC -58.1774 58.2574 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments